Americans starting weight-loss medicines for the first time want lower cost and greater convenience as they consider pills from Novo Nordisk NOVOb.CO or Eli Lilly LLY.N, according to seven doctors who ...

THERE IS A NEW GROCERY STORE CHAIN COMING TO TOWN. WE TOLD YOU ABOUT THIS YESTERDAY. WEGMANS, BASED IN ROCHESTER, NEW YORK, IS COMING HERE TO PITTSBURGH. THE NEW STORE THEY’RE PLANNING IN CRANBERRY ...

GLP-1 medications are now available as both pills and injections, offering more options for weight loss treatment. The two forms work similarly and have comparable results, but differ in dosing, ...

If you’re on a weight loss journey, you now have an arsenal of medications at your disposal. And while injectable medications have dominated the space for years, GLP-1 weight loss pills are now on the ...

The approval of a second GLP-1 weight-loss pill Wednesday adds another medication to the market for people with obesity and diabetes. But whether these new options will make it easier and cheaper to ...

Imagine that you're pregnant, a few weeks in, and you decide you want an abortion. You walk into a retail pharmacy, and pick up a package on the shelf that says "medication abortion kit." You buy it ...

The U.S. Food and Drug Administration’s approval of Eli Lilly’s once-daily pill orforglipron as a weight loss and obesity treatment this week was the fastest approval of a new medication in decades.

The Food and Drug Administration on April 1 approved Eli Lilly's new weight-loss pill, giving consumers a second option in the growing non-injectable GLP-1 weight-loss drug market. Lilly said it will ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. INDIANAPOLIS, INDIANA - MARCH 17: A flag flies above the headquarters campus of Eli Lilly ...

Much to the relief of the needle-shy, the Food and Drug Administration has just approved a second oral GLP-1 drug, following the release of the semaglutide Wegovy pill in January. But this new tablet, ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...